Bausch + Lomb Sets February Date to Report 2025 Results

Bausch + Lomb Corporation ( (BLCO) ) has issued an update.

Bausch + Lomb will release its fourth-quarter and full-year 2025 financial results on February 18, 2026, and will discuss the figures and provide a business update during an 8 a.m. ET conference call and live webcast for investors. The planned disclosure underscores the company’s ongoing engagement with the financial community and offers stakeholders an opportunity to assess its recent performance and strategic direction in the competitive global eye health industry.

The most recent analyst rating on (BLCO) stock is a Hold with a $18.50 price target. To see the full list of analyst forecasts on Bausch + Lomb Corporation stock, see the BLCO Stock Forecast page.

Spark’s Take on BLCO Stock

According to Spark, TipRanks’ AI Analyst, BLCO is a Neutral.

Overall score reflects a balance between weak underlying financial performance (losses and negative free cash flow) and a more positive forward narrative from the earnings call (solid segment-led revenue growth and maintained guidance). Technicals are neutral-to-mildly supportive, while valuation is constrained by the negative P/E and lack of dividend yield data; corporate actions modestly improve the outlook via refinancing and governance upgrades.

To see Spark’s full report on BLCO stock, click here.

More about Bausch + Lomb Corporation

Bausch + Lomb Corporation is a leading global eye health company focused on improving vision through a broad portfolio that spans contact lenses, prescription eye-care products, over-the-counter treatments and surgical devices. With a nearly 200-year history and a strong emphasis on innovation, the company targets patients and eye-care professionals worldwide, aiming to raise standards of care across the vision health market.

Average Trading Volume: 416,340

Technical Sentiment Signal: Buy

Current Market Cap: $6.08B

See more insights into BLCO stock on TipRanks’ Stock Analysis page.